The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nemvaleukin alfa combination therapy for gastrointestinal (GI) cancers: Preclinical evidence and clinical data from the ARTISTRY-1 trial.
 
Ulka N. Vaishampayan
Consulting or Advisory Role - Advanced Accelerator Applications; Alkermes; Bayer; Bristol-Myers Squibb/Medarex; Exelixis; Helsinn Therapeutics; Merck Serono; Pfizer
Speakers' Bureau - Bayer; Exelixis; Pfizer
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Exelixis; Merck KGaA
 
Shipra Gandhi
Consulting or Advisory Role - Immunomedics
 
Seth David Rosen
No Relationships to Disclose
 
Anna Spreafico
Honoraria - Bristol-Myers Squibb; Janssen Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Oncorus
Research Funding - Alkermes; Array BioPharma; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck; Northern Biologics; Novartis; Replimune; Roche; Surface Oncology; Symphogen; Treadwell Therapeutics (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Idera; Janssen Oncology; Merck; Roche
 
Debora S. Bruno
Consulting or Advisory Role - Tempus
 
Quincy S. Chu
Honoraria - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Lilly; Merck; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Lilly; Merck; Novartis; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Boehringer Ingelheim
 
Aman Chauhan
Honoraria - Ipsen; Lexicon; Novartis; TerSera
Consulting or Advisory Role - Ipsen; Lexicon; Novartis; TerSera
Research Funding - Bristol-Myers Squibb; Clovis Oncology
 
Olivier Dumas
No Relationships to Disclose
 
Hal W. Hirte
Honoraria - AstraZeneca Canada; GlaxoSmithKline; Merck
Consulting or Advisory Role - AstraZeneca Canada; Merck
 
Jared E. Lopes
Employment - Alkermes
Stock and Other Ownership Interests - Alkermes
 
Heather Losey
Employment - Alkermes; Takeda (I)
Stock and Other Ownership Interests - Alkermes; Takeda (I)
Patents, Royalties, Other Intellectual Property - Alkermes; Takeda (I)
 
Yan Wang
Employment - Alkermes
Stock and Other Ownership Interests - Alkermes
 
Lei Sun
Employment - Alkermes
Stock and Other Ownership Interests - Alkermes
Patents, Royalties, Other Intellectual Property - Coauthor U.S. Patent Application No: 16/898,008. Compositions and Methods for Cancer Immunotherapy. Coauthor U.S. Patent Application No: 16/897,920. Compositions and Methods for Subcutaneous Administration of Cancer Immunotherapy. (Inst)
Travel, Accommodations, Expenses - Alkermes
 
Monali Bhardwaj Desai
Employment - Alkermes
Stock and Other Ownership Interests - Alkermes
 
Rita P. Dalal
Employment - Alkermes
Stock and Other Ownership Interests - Alkermes
 
Yangchun Du
Employment - Alkermes
Stock and Other Ownership Interests - Alkermes
 
Julie R. Graham
Employment - Alkermes
Stock and Other Ownership Interests - Alkermes
 
Jameel Muzaffar
No Relationships to Disclose
 
Ira Seth Winer
Research Funding - Oncoceutics